Endocrine Therapy
Showing 1 - 25 of >10,000
Breast Cancer Trial (Standard of care administration of Endocrine therapy, Dose-frequency escalation administration of Endocrine
Not yet recruiting
- Breast Cancer
- Standard of care administration of Endocrine therapy
- Dose-frequency escalation administration of Endocrine therapy
- (no location specified)
Feb 22, 2023
CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent
Not yet recruiting
- Breast Cancer
- +3 more
- Different treatment regimens following progression on CDK4/6 inhibitors.
- (no location specified)
Sep 5, 2023
Breast Cancer. Real Clinical Practice in Russia
Recruiting
- Breast Cancer
- Neoadjuvant Endocrine Therapy
- Tamoxifen 20mg
- +4 more
-
Moscow, Russian FederationBlokhin's Russian Cancer Research Center
Apr 5, 2023
Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and
Not yet recruiting
- Breast Cancer
- Advanced Breast Cancer
- Everolimus 10 mg
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 14, 2023
Breast Cancer Trial in Beijing, Guangzhou (TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole,
Not yet recruiting
- Breast Cancer
- TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
- Placebo capsules, Letrozole, Anastrozole, Tamoxifen
-
Beijing, Beijing, China
- +1 more
Mar 10, 2023
Breast Cancer, Hot Flash Due to Medication Trial (Oxybutynin, Venlafaxine)
Not yet recruiting
- Breast Cancer
- Hot Flash Due to Medication
- (no location specified)
Oct 24, 2023
Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)
Not yet recruiting
- Locally Advanced or Metastatic Breast Cancer
- SPH4336 Tablets
- SPH4336 Tablets Placebo
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023
Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)
Recruiting
- Breast Cancer
- Capecitabine+endocrine therapy
- Placebo+endocrine therapy
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Nov 19, 2022
Insomnia, Breast Cancer, Adherence, Medication Trial in Glasgow (Cognitive behavioural therapy for insomnia)
Recruiting
- Insomnia
- +4 more
- Cognitive behavioural therapy for insomnia
-
Glasgow, County (optional), United KingdomUniversity of Strathclyde
May 31, 2023
Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,
Recruiting
- Metastatic Cancer
- +2 more
- 18F-fluorofuranylnorprogesterone
- +2 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 10, 2023
Breast Cancer Trial in Wuhan (Adebrelimab, dalpiciclib)
Recruiting
- Breast Cancer
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 20, 2023
Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy
Recruiting
- Advanced Breast Cancer
- The combination of Dalpiciclib with physician-selected endocrine therapy
- Chemotherapy selected by the physician
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Breast Cancer Trial in New York (core needle biopsy, blood draw)
Recruiting
- Breast Cancer
- core needle biopsy
- blood draw
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 9, 2023
Female Breast Cancer Trial in Sohag (Hormonal Antineoplastics, Chemotherapy drug)
Not yet recruiting
- Female Breast Cancer
- Hormonal Antineoplastics
- Chemotherapy drug
-
Sohag, Egyptamal Ali
Feb 23, 2023
Breast Cancer Trial in Ottawa, Thunder Bay (Morning administration of endocrine therapy, Evening administration of endocrine
Active, not recruiting
- Breast Cancer
- Morning administration of endocrine therapy
- Evening administration of endocrine therapy
-
Ottawa, Ontario, Canada
- +1 more
Sep 21, 2022
Breast Cancer Trial in Ottawa (No endocrine therapy, Endocrine therapy)
Recruiting
- Breast Cancer
- No endocrine therapy
- Endocrine therapy
-
Ottawa, Ontario, CanadaThe Ottawa Hospital
Sep 13, 2022
Induced Alopecia Among Postmenopausal and Premenopausal Female
Recruiting
- Breast Carcinoma
- Electronic Health Record Review
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Breast Cancer Brain Metastases Trial in Guangzhou (SPH4336 Tablets)
Not yet recruiting
- Breast Cancer Brain Metastases
- SPH4336 Tablets
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 24, 2023
Early-stage Breast Cancer Trial in Ottawa (Endocrine Therapy and Radiotherapy)
Completed
- Early-stage Breast Cancer
- Endocrine Therapy and Radiotherapy
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Sep 28, 2022
Advanced HR+ HER2 Negative Breast Carcinoma Trial ((CDK)4/6 inhibitor)
Not yet recruiting
- Advanced HR+ HER2 Negative Breast Carcinoma
- (CDK)4/6 inhibitor
- (no location specified)
Sep 27, 2022
Breast Cancer Trial in Tianjin (Dalcelli?Exemestane?Gosserine, Docetaxel for injection?Epirubicin HCl for
Recruiting
- Breast Cancer
- Dalcelli、Exemestane、Gosserine
- Docetaxel for injection、Epirubicin hydrochloride for injection、Cyclophosphamide for injection
-
Tianjin, Tianjin, ChinaJie Ge
Aug 20, 2023
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +4 more
- (no location specified)
Mar 7, 2023
Breast Tumors, Breast Cancer Trial (PACHA Program)
Not yet recruiting
- Breast Neoplasms
- Breast Cancer
- PACHA Program
- (no location specified)
Jun 6, 2023